TREVI THERAPEUTICS INC (TRVI)

US89532M1018 - Common Stock

2.94  -0.08 (-2.65%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
33.92M29.91M32.48M32.49M26.65M
Research and Development
23.68M19.83M22.98M22.33M19.34M
Selling, General, and Administrative Expenses
10.24M10.07M9.49M10.16M7.31M
Operating Income
-33.92M-29.91M-32.48M-32.49M-26.65M
Interest Income/Expense
4.36M430.00K-1.11M-290.00K580.00K
Other Income/Expense
469.00K290.00K-380.00KN/A0.00
Income Before Taxes
-29.10M-29.19M-33.96M-32.78M-26.07M
Income Tax
-32.00K-40.00K-20.00K-20.00K-20.00K
Net Income
-29.07M-29.15M-33.94M-32.76M-26.75M
EBITDA
-33.80M-29.87M-32.43M-32.44M-26.61M
 
Per Share Data
EPS Diluted Total Ops
-0.29-0.45-1.49-1.81-2.28
Non GAAP EPS
-0.29-0.56-1.52-1.81N/A
 
Statistics

All data in USD

Charts